Annual Shareholders Equity
$473.58 M
+$160.23 M+51.14%
31 December 2023
Summary:
Pliant Therapeutics annual stockholders equity is currently $473.58 million, with the most recent change of +$160.23 million (+51.14%) on 31 December 2023. During the last 3 years, it has risen by +$190.51 million (+67.31%). PLRX annual shareholders equity is now at all-time high.PLRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$345.82 M
-$46.86 M-11.93%
30 September 2024
Summary:
Pliant Therapeutics quarterly stockholders equity is currently $345.82 million, with the most recent change of -$46.86 million (-11.93%) on 30 September 2024. Over the past year, it has dropped by -$157.23 million (-31.25%). PLRX quarterly shareholders equity is now -38.46% below its all-time high of $561.92 million, reached on 31 March 2023.PLRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLRX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.1% | -31.3% |
| 3 y3 years | +67.3% | +56.9% |
| 5 y5 years | +10000.0% | - |
PLRX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +137.9% | -38.5% | +134.0% |
| 5 y | 5 years | at high | >+9999.0% | -38.5% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -38.5% | >+9999.0% |
Pliant Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $345.82 M(-11.9%) |
| June 2024 | - | $392.68 M(-10.2%) |
| Mar 2024 | - | $437.33 M(-7.7%) |
| Dec 2023 | $473.58 M(+51.1%) | $473.58 M(-5.9%) |
| Sept 2023 | - | $503.05 M(-5.6%) |
| June 2023 | - | $533.07 M(-5.1%) |
| Mar 2023 | - | $561.92 M(+79.3%) |
| Dec 2022 | $313.34 M(+57.4%) | $313.34 M(-7.0%) |
| Sept 2022 | - | $336.99 M(+128.0%) |
| June 2022 | - | $147.79 M(-15.0%) |
| Mar 2022 | - | $173.79 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $199.06 M(-29.7%) | $199.06 M(-9.7%) |
| Sept 2021 | - | $220.44 M(-9.6%) |
| June 2021 | - | $243.98 M(-7.6%) |
| Mar 2021 | - | $264.17 M(-6.7%) |
| Dec 2020 | $283.06 M(<-9900.0%) | $283.06 M(-5.8%) |
| Sept 2020 | - | $300.35 M(-4.9%) |
| June 2020 | - | $315.82 M(+82.0%) |
| Mar 2020 | - | $173.56 M(<-9900.0%) |
| Dec 2019 | -$435.00 K(-50.7%) | -$435.00 K(-101.2%) |
| June 2019 | - | $36.87 M(+1.9%) |
| Dec 2018 | -$882.00 K | - |
| Dec 2018 | - | $36.19 M |
FAQ
- What is Pliant Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Pliant Therapeutics?
- What is Pliant Therapeutics annual shareholders equity year-on-year change?
- What is Pliant Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly shareholders equity year-on-year change?
What is Pliant Therapeutics annual stockholders equity?
The current annual shareholders equity of PLRX is $473.58 M
What is the all time high annual shareholders equity for Pliant Therapeutics?
Pliant Therapeutics all-time high annual stockholders equity is $473.58 M
What is Pliant Therapeutics annual shareholders equity year-on-year change?
Over the past year, PLRX annual stockholders equity has changed by +$160.23 M (+51.14%)
What is Pliant Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PLRX is $345.82 M
What is the all time high quarterly shareholders equity for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly stockholders equity is $561.92 M
What is Pliant Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, PLRX quarterly stockholders equity has changed by -$157.23 M (-31.25%)